Sun Pharmaceutical advanced as much as 2.17 percent on Thursday as the pharma major got a go-ahead from the US Food and Drug Administration (USFDA) for its ophthalmic drug.
For Real Time News & Trading Trends Keep Liking Epic Research Limited
For more information on Equity Market News Call us ✆ – 0731-6642300 or Visit http://www.epicresearch.co
Connect with our social media sites
Follow @Epic_Research
No comments:
Post a Comment